loadpatents
name:-0.081328153610229
name:-0.064929008483887
name:-0.0057327747344971
Nakamura; Kazuyasu Patent Filings

Nakamura; Kazuyasu

Patent Applications and Registrations

Patent applications and USPTO patent grants for Nakamura; Kazuyasu.The latest application filed is for "method of producing antibodies with n-glycoside-linked sugar chains lacking fucosylation".

Company Profile
5.70.78
  • Nakamura; Kazuyasu - Machida JP
  • NAKAMURA; Kazuyasu - Machida-shi JP
  • Nakamura; Kazuyasu - Tokyo JP
  • Nakamura; Kazuyasu - Chiyoda-ku JP
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Human CDR-grafted antibody and antibody fragment thereof
Grant 10,590,203 - Shitara , et al.
2020-03-17
Method Of Producing Antibodies With N-glycoside-linked Sugar Chains Lacking Fucosylation
App 20200017593 - HANAI; Nobuo ;   et al.
2020-01-16
Antibody Composition-producing Cell
App 20190360015 - Kanda; Yutaka ;   et al.
2019-11-28
Method of modulating the activity of functional immune molecules
Grant 10,233,247 - Hanai , et al.
2019-03-19
Antibody composition-producing cell
Grant 10,233,475 - Kanda , et al.
2019-03-19
Human CDR-grafted antibody and antibody fragment thereof
Grant 10,131,711 - Shitara , et al. November 20, 2
2018-11-20
Human Cdr-grafted Antibody And Antibody Fragment Thereof
App 20180030146 - SHITARA; Kenya ;   et al.
2018-02-01
Method Of Modulating The Activity Of Functional Immune Molecules
App 20170240647 - HANAI; Nobuo ;   et al.
2017-08-24
Antibody Composition-producing Cell
App 20160348145 - KANDA; Yutaka ;   et al.
2016-12-01
Antibody composition-producing cell
Grant 9,409,982 - Kanda , et al. August 9, 2
2016-08-09
Human Cdr-grafted Antibody And Antibody Fragment Thereof
App 20150315285 - SHITARA; Kenya ;   et al.
2015-11-05
Human CDR-grafted antibody and antibody fragment thereof
Grant 9,051,371 - Shitara , et al. June 9, 2
2015-06-09
Antibody Composition-producing Cell
App 20150112046 - KANDA; Yutaka ;   et al.
2015-04-23
Human CDR-grafted antibody and antibody fragment thereof
Grant 8,900,584 - Shitara , et al. December 2, 2
2014-12-02
Antibody composition-producing cell
Grant 8,895,266 - Kanda , et al. November 25, 2
2014-11-25
Anti-CD4 antibody
Grant 8,877,913 - Nakagawa , et al. November 4, 2
2014-11-04
Method Of Modulating The Activity Of Functional Immune Molecules
App 20140234300 - HANAI; Nobuo ;   et al.
2014-08-21
Human Cdr-grafted Antibody And Antibody Fragment Thereof
App 20140186349 - Shitara; Kenya ;   et al.
2014-07-03
Method of modulating the activity of functional immune molecules
Grant 8,679,491 - Hanai , et al. March 25, 2
2014-03-25
Method for producing recombinant antibody and antibody fragment thereof
Grant 8,632,996 - Shitara , et al. January 21, 2
2014-01-21
Monoclonal Antibody Capable Of Binding To Heparin-binding Epidermal Growth Factor-like Growth Factor
App 20130337505 - MEKADA; Eisuke ;   et al.
2013-12-19
Human Cdr-grafted Antibody And Antibody Fragment Thereof
App 20130273038 - SHITARA; Kenya ;   et al.
2013-10-17
Antibody Composition-producing Cell
App 20130189736 - KANDA; Yutaka ;   et al.
2013-07-25
Anti-cd4 Antibody
App 20130177944 - NAKAGAWA; Tomoaki ;   et al.
2013-07-11
Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor
Grant 8,481,039 - Mekada , et al. July 9, 2
2013-07-09
Anti-CD4 antibody
Grant 8,399,621 - Nakagawa , et al. March 19, 2
2013-03-19
Cells with altered fucosylation and producing antibodies therefrom
Grant 8,367,407 - Kanda , et al. February 5, 2
2013-02-05
Antibody composition-producing cell
Grant 8,329,443 - Kanda , et al. December 11, 2
2012-12-11
Method of enhancing of binding activity of antibody composition to Fc.gamma. receptor IIIa
Grant 8,313,913 - Nakamura , et al. November 20, 2
2012-11-20
Gene Recombinant Antibody And Antibody Fragment Thereof
App 20120276090 - SHITARA; Kenya ;   et al.
2012-11-01
Anti-trop-2 Antibody
App 20120237518 - YAMAGUCHI; Miki ;   et al.
2012-09-20
Human Cdr-grafted Antibody And Antibody Fragment Thereof
App 20120177643 - Shitara; Kenya ;   et al.
2012-07-12
Monoclonal Antibody Capable Of Binding To Heparin-binding Epidermal Growth Factor-like Growth Factor
App 20120177649 - MEKADA; Eisuke ;   et al.
2012-07-12
Method for treating the Th2-mediated disease
Grant 8,197,814 - Shitara , et al. June 12, 2
2012-06-12
Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor
Grant 8,173,781 - Mekada , et al. May 8, 2
2012-05-08
Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor
Grant 8,163,282 - Mekada , et al. April 24, 2
2012-04-24
Glycoengineered, recombinant antibody
Grant 8,158,760 - Kanda , et al. April 17, 2
2012-04-17
Human CDR-grafted antibody and antibody fragment thereof
Grant 8,143,058 - Shitara , et al. March 27, 2
2012-03-27
Antibody composition exhibiting cellular cytotoxicity due to glycosylation and containing ganglioside GM2 binding antibody
Grant 8,110,195 - Kanda , et al. February 7, 2
2012-02-07
Anti-il-5 antibody composition exhibiting cellular cytotoxicity due to glycosylation
Grant 8,101,185 - Kanda , et al. January 24, 2
2012-01-24
Anti-PERP recombinant antibody
Grant 8,093,362 - Ochiai , et al. January 10, 2
2012-01-10
Anti-claudin-4 antibody
Grant 8,076,458 - Ohta , et al. December 13, 2
2011-12-13
Antibody composition-producing cell with inactivated A-1,6-fusocyltransferase
Grant 8,067,232 - Kanda , et al. November 29, 2
2011-11-29
Glycoengineered, recombinant antibody to CCR-4 with reduced fucosylation
Grant 8,039,595 - Kanda , et al. October 18, 2
2011-10-18
Antibody Composition-producing Cell
App 20110250643 - KANDA; Yutaka ;   et al.
2011-10-13
Humanized antibody against fibroblast growth factor-8 and antibody fragment thereof
Grant 7,939,077 - Shitara , et al. May 10, 2
2011-05-10
Antibody Composition Exhibiting Cellular Cytotoxicty Due To Glycosylation
App 20110059115 - KANDA; YUTAKA ;   et al.
2011-03-10
Human Cdr-grafted Antibody And Antibody Fragment Thereof
App 20110059524 - SHITARA; Kenya ;   et al.
2011-03-10
Antibody Composition Exhibiting Cellular Cytotoxicty Due To Glycosylation
App 20110052610 - Kanda; Yutaka ;   et al.
2011-03-03
Monoclonal Antibody Capable Of Binding To Heparin-binding Epidermal Growth Factor-like Growth Factor
App 20110052595 - MEKADA; Eisuke ;   et al.
2011-03-03
Monoclonal Antibody Capable Of Binding To Heparin-binding Epidermal Growth Factor-like Growth Factor
App 20110034673 - MEKADA; Eisuke ;   et al.
2011-02-10
Antibody Composition Exhibiting Cellular Cytotoxicty Due To Glycosylation
App 20110027271 - KANDA; Yutaka ;   et al.
2011-02-03
Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor
Grant 7,851,601 - Mekada , et al. December 14, 2
2010-12-14
Anti-cd4 Antibody
App 20100310573 - NAKAGAWA; Tomoaki ;   et al.
2010-12-09
Antibody composition-producing cell in which enzyme expression is inhibited by RNAi
Grant 7,846,725 - Kanda , et al. December 7, 2
2010-12-07
Human CDR-grafted antibody and antibody fragment thereof
Grant 7,842,797 - Shitara , et al. November 30, 2
2010-11-30
Method for Treating the TH2-Mediated Disease
App 20100221178 - SHITARA; Kenya ;   et al.
2010-09-02
Method Of Modulating The Activity Of Functional Immune Molecules
App 20100196371 - HANAI; NOBUO ;   et al.
2010-08-05
Method of modulating the activity of functional immune molecules to platelet-derived growth factor receptor
Grant 7,763,246 - Hanai , et al. July 27, 2
2010-07-27
Monoclonal Antibody Capable Of Binding To Heparin-binding Epidermal Growth Factor-like Growth Factor
App 20100184958 - MEKADA; EISUKE ;   et al.
2010-07-22
Antibody composition exhibiting increased cellular cytotoxicity due to glycosylation
Grant 7,741,442 - Kanda , et al. June 22, 2
2010-06-22
Antibody composition-producing cell
Grant 7,737,325 - Kanda , et al. June 15, 2
2010-06-15
Antibody Composition-Producing Cell
App 20100143388 - KANDA; YUTAKA ;   et al.
2010-06-10
Method of modulating the activity of functional immune molecules to interleukin-5 receptor protein
Grant 7,718,175 - Hanai , et al. May 18, 2
2010-05-18
Method of modulating the activity of functional immune molecules
Grant 7,708,997 - Hanai , et al. May 4, 2
2010-05-04
Methods for producing antibody compositions with increased ADCC
Grant 7,708,992 - Hanai , et al. May 4, 2
2010-05-04
Method of Enhancing of Binding Activity of Antibody Composition to FcGamma Receptor IIIa
App 20100092997 - Nakamura; Kazuyasu ;   et al.
2010-04-15
Method of modulating the activity of functional immune molecules to Her-2
Grant 7,687,061 - Hanai , et al. March 30, 2
2010-03-30
Method of modulating the activity of functional immune molecules to CXCR4 protein
Grant 7,682,611 - Hanai , et al. March 23, 2
2010-03-23
Method of modulating the activity of functional immune molecules
Grant 7,682,610 - Hanai , et al. March 23, 2
2010-03-23
Method for treating Th2-mediated disease
Grant 7,666,418 - Shitara , et al. February 23, 2
2010-02-23
Method of modulating the activity of functional immune molecules to GM2
Grant 7,655,228 - Hanai , et al. February 2, 2
2010-02-02
Method of modulating the activity of functional immune molecules to CD52
Grant 7,651,688 - Hanai , et al. January 26, 2
2010-01-26
Anti-human VEGF receptor Flt-1 monoclonal antibody
Grant 7,615,215 - Shitara , et al. November 10, 2
2009-11-10
Anti-human VEGF receptor Flt-1 monoclonal antibody
Grant 7,615,214 - Shitara , et al. November 10, 2
2009-11-10
Human CDR-Grafted Antibody and Antibody Fragment Thereof
App 20090227012 - SHITARA; Kenya ;   et al.
2009-09-10
Antibody Composition-Producing Cell
App 20090228994 - KANDA; Yutaka ;   et al.
2009-09-10
Anti-claudin-4 Antibody
App 20090202556 - OHTA; So ;   et al.
2009-08-13
Glycoengineered, Recombinant Antibody
App 20090191199 - KANDA; Yutaka ;   et al.
2009-07-30
Glycoengineered, Recombinant Antibody
App 20090191592 - KANDA; Yutaka ;   et al.
2009-07-30
Human CDR-grafted antibody and antibody fragment thereof
Grant 7,504,104 - Shitara , et al. March 17, 2
2009-03-17
Recombinant antibody against human insulin-like growth factor
Grant 7,498,415 - Shitara , et al. March 3, 2
2009-03-03
Anti-perp recombinant antibody
App 20080267953 - Ochiai; Atsushi ;   et al.
2008-10-30
Antibody Composition-Producing Cell
App 20080261301 - Kanda; Yutaka ;   et al.
2008-10-23
Antibody against human insulin-like growth factor
Grant 7,438,911 - Shitara , et al. October 21, 2
2008-10-21
Fused Protein Composition
App 20080241884 - Shitara; Kenya ;   et al.
2008-10-02
Antibody Composition-Producing Cell
App 20080227196 - Kanda; Yutaka ;   et al.
2008-09-18
Antibody composition-producing cell
Grant 7,425,446 - Kanda , et al. September 16, 2
2008-09-16
Anti-human Vegf Receptor Flt-1 Monoclonal Antibody
App 20080187529 - Shitara; Kenya ;   et al.
2008-08-07
Methods using eosinophil-specific apoptosis inducer
Grant 7,404,953 - Hosaka , et al. July 29, 2
2008-07-29
Method of Modulating the Activity of Functional Immune Molecules
App 20080177043 - Hanai; Nobuo ;   et al.
2008-07-24
Mammalian host cell modified by RNAi to inhibit .alpha. 1,6-fucosyltransferase
Grant 7,393,683 - Kanda , et al. July 1, 2
2008-07-01
Method of Modulating the Activity of Functional Immune Molecules
App 20070207151 - Hanai; Nobuo ;   et al.
2007-09-06
Complementarity determining region-grafted antibody against ganglioside GD3 and derivative of antibody against ganglioside GD3
Grant 7,253,263 - Hanai , et al. August 7, 2
2007-08-07
Method of Modulating the Activity of Functional Immune Molecules
App 20070166300 - Hanai; Nobuo ;   et al.
2007-07-19
Method of Modulating the Activity of Functional Immune Molecules
App 20070166305 - Hanai; Nobuo ;   et al.
2007-07-19
Method of Modulating the Activity of Functional Immune Molecules
App 20070166302 - Hanai; Nobuo ;   et al.
2007-07-19
Method of Modulating the Activity of Functional Immune Molecules
App 20070166301 - Hanai; Nobuo ;   et al.
2007-07-19
Method of Modulating the Activity of Functional Immune Molecules
App 20070166303 - Hanai; Nobuo ;   et al.
2007-07-19
Method of Modulating the Activity of Functional Immune Molecules
App 20070166304 - Hanai; Nobuo ;   et al.
2007-07-19
Anti-fibroblast growth factor-8 monoclonal antibody
Grant 7,241,568 - Hanai , et al. July 10, 2
2007-07-10
Method of treating atopic dermatitis using antibody against human interleukin-5 receptor alpha chain
Grant 7,238,354 - Koike , et al. July 3, 2
2007-07-03
Method of modulating the activity of functional immune molecules
Grant 7,214,775 - Hanai , et al. May 8, 2
2007-05-08
Method of treating allergy using antibody against human interleukin-5 receptor alpha chain
App 20070048304 - Koike; Masamichi ;   et al.
2007-03-01
Method of treatment by administering an antibody to human interleukin-5 receptor .alpha. chain
Grant 7,179,464 - Koike , et al. February 20, 2
2007-02-20
Antibody Composition-Producing Cell
App 20070010009 - Kanda; Yutaka ;   et al.
2007-01-11
Cancer metastasis inhibitor
App 20060263362 - Ochiai; Atsushi ;   et al.
2006-11-23
Recombinant antibody against human insulin-like growth factor
App 20060240015 - Shitara; Kenya ;   et al.
2006-10-26
Antibody against human insulin-like growth factor
App 20060165695 - Shitara; Kenya ;   et al.
2006-07-27
Anti-human VEGF receptor FLT-1 monoclonal antibody
Grant 7,052,693 - Shitara , et al. May 30, 2
2006-05-30
Antibody composition-producing cell
App 20060078990 - Kanda; Yutaka ;   et al.
2006-04-13
Antibody composition-producing cell
App 20060078991 - Kanda; Yutaka ;   et al.
2006-04-13
Antibody composition-producing cell
App 20060063254 - Kanda; Yutaka ;   et al.
2006-03-23
Antibody composition-producing cell
App 20060064781 - Kanda; Yutaka ;   et al.
2006-03-23
Anti-human VEGF receptor Flt-1 monoclonal antibody
App 20060034838 - Shitara; Kenya ;   et al.
2006-02-16
Method of modulating the activity of functional immune molecules
App 20060024800 - Hanai; Nobuo ;   et al.
2006-02-02
Recombinant antibody and antibody fragment
Grant 6,989,145 - Shitara , et al. January 24, 2
2006-01-24
Anti-human VEGF receptor Flt-1 monoclonal antibody
Grant 6,986,890 - Shitara , et al. January 17, 2
2006-01-17
Method of modulating the activity of functional immune molecules
App 20050276805 - Hanai, Nobuo ;   et al.
2005-12-15
Method of modulating the activity of functional immune molecules
App 20050272916 - Hanai, Nobuo ;   et al.
2005-12-08
Method of treating allergy using antibody against human interleukin-5 receptor alpha chain
App 20050272918 - Koike, Masamichi ;   et al.
2005-12-08
Antibody composition-producing cell
App 20050262593 - Kanda, Yutaka ;   et al.
2005-11-24
Cells producing antibody compositions with increased antibody dependent cytotoxic activity
Grant 6,946,292 - Kanda , et al. September 20, 2
2005-09-20
Method for treating Th2-mediated disease
App 20050187380 - Shitara, Kenya ;   et al.
2005-08-25
Humanized antibodies
Grant 6,872,392 - Nakamura , et al. March 29, 2
2005-03-29
Therapeutic agent for patients having human FcgammaRIIIa
App 20050031613 - Nakamura, Kazuyasu ;   et al.
2005-02-10
Method of enhancing of binding activity of antibody composition to Fcgamma receptor IIIa
App 20040259150 - Nakamura, Kazuyasu ;   et al.
2004-12-23
Humanized antibody against fibroblast growth factor-8 and antibody fragment thereof
App 20040253234 - Shitara, Kenya ;   et al.
2004-12-16
Eosinophil-specific apoptosis inducer
App 20040136996 - Hosaka, Emi ;   et al.
2004-07-15
Anti-fibroblast growth factor-8 monoclonal antibody
App 20040091480 - Hanai, Nobuo ;   et al.
2004-05-13
Human CDR-grafted antibody and antibody fragment thereof
App 20030175273 - Shitara, Kenya ;   et al.
2003-09-18
Antibody composition-producing cell
App 20030115614 - Kanda, Yutaka ;   et al.
2003-06-19
Antibody against human interleukin-5 receptor alpha chain
App 20030096977 - Koike, Masamichi ;   et al.
2003-05-22
Anti-human VEGF receptor Flt-1 monoclonal antibody
App 20030088075 - Shitara, Kenya ;   et al.
2003-05-08
Humanized antibodies
App 20030077276 - Nakamura, Kazuyasu ;   et al.
2003-04-24
Gene recombinant antibody and antibody fragment thereof
App 20020098527 - Shitara, Kenya ;   et al.
2002-07-25
Antibody against human interleukin-5-receptor .alpha. chain
Grant 6,018,032 - Koike , et al. January 25, 2
2000-01-25
Humanized antibodies to ganglioside GM.sub.2
Grant 5,939,532 - Nakamura , et al. August 17, 1
1999-08-17
DNA encoding humanized antibodies specific for the ganglioside GM.sub.2
Grant 5,874,255 - Nakamura , et al. February 23, 1
1999-02-23

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed